Matches in Wikidata for { <http://www.wikidata.org/entity/Q65542226> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q65542226 description "clinical trial" @default.
- Q65542226 description "ensayu clínicu" @default.
- Q65542226 description "klinisch onderzoek" @default.
- Q65542226 description "клінічне випробування" @default.
- Q65542226 description "կլինիկական փորձարկում" @default.
- Q65542226 name "Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer" @default.
- Q65542226 name "Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer" @default.
- Q65542226 type Item @default.
- Q65542226 label "Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer" @default.
- Q65542226 label "Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer" @default.
- Q65542226 prefLabel "Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer" @default.
- Q65542226 prefLabel "Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer" @default.
- Q65542226 P1132 Q65542226-72E2F7DE-7D45-42A0-BAAA-88356BC0D6AC @default.
- Q65542226 P1476 Q65542226-A7BFF849-5C9A-4A89-932D-9B0E0EFE3627 @default.
- Q65542226 P17 Q65542226-B8F669BE-3F67-4AB2-9EBD-F7F322A40FF1 @default.
- Q65542226 P2899 Q65542226-C379C815-F5FE-4E91-87CA-B81BC9395CF5 @default.
- Q65542226 P3098 Q65542226-8ED1167F-0AA8-4B0B-A945-C38AC47C3E04 @default.
- Q65542226 P31 Q65542226-9F3F3583-9FFC-4EA7-9391-C602E71D0FC9 @default.
- Q65542226 P4844 Q65542226-DE78F926-95C4-4D94-8A6E-17BF633BC4F6 @default.
- Q65542226 P580 Q65542226-B78EDA3B-1C22-43AF-95AB-DE9E9BDC6BFA @default.
- Q65542226 P582 Q65542226-E3E82CFB-B627-452F-A020-06D156D50D49 @default.
- Q65542226 P6099 Q65542226-46FA4E36-5DF6-42E5-AAEE-4C18FE49C7B7 @default.
- Q65542226 P8363 Q65542226-998F11F4-CC84-4849-BECD-D2A776110932 @default.
- Q65542226 P1132 "+74" @default.
- Q65542226 P1476 "Phase I Study of Tipifarnib (R115777) and Sorafenib (BAY 43-9006) in Patients With Biopsiable Advanced Cancers" @default.
- Q65542226 P17 Q30 @default.
- Q65542226 P2899 "+18" @default.
- Q65542226 P3098 "NCT00244972" @default.
- Q65542226 P31 Q30612 @default.
- Q65542226 P4844 Q7808830 @default.
- Q65542226 P580 "2005-10-01T00:00:00Z" @default.
- Q65542226 P582 "2017-03-01T00:00:00Z" @default.
- Q65542226 P6099 Q5452194 @default.
- Q65542226 P8363 Q78089383 @default.